SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 165.61 |
| Enterprise Value ($M) | 137.20 |
| Book Value ($M) | 8.43 |
| Book Value / Share | 0.07 |
| Price / Book | 19.65 |
| NCAV ($M) | -1.74 |
| NCAV / Share | -0.01 |
| Price / NCAV | -95.29 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.25 |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | -1.17 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.72 |
| Current Ratio | 2.72 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 168.96 |
| Assets | 179.13 |
| Liabilities | 170.70 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 36.85 |
| Operating Income | -170.96 |
| Net Income | -171.67 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -168.88 |
| Cash from Investing | 119.88 |
| Cash from Financing | 94.67 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Nextech Crossover I GP S.a r.l. | 5.10 | ||
| 13G/A | Orbimed Advisors Llc | 0.00 | -100.00 | |
| 13G | Silverarc Capital Management, Llc | 5.30 | ||
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 9.40 | 17.05 | |
| 13G | Balyasny Asset Management Llc | 8.04 | ||
| 13G/A | Avoro Capital Advisors LLC | 0.00 | -100.00 | |
| 13G | Vanguard Group Inc | 5.17 | 40.20 | |
| 13G/A | BlackRock Inc. | 6.50 | 4.70 | |
| 13G/A | State Street Corp | 1.93 | -60.22 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 188,075 | 970,473 | 19.38 | |
| 230,217 | 755,708 | 30.46 | |
| 161,054 | 933,148 | 17.26 | |
| 97,238 | 409,917 | 23.72 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MLYS – Mineralys Therapeutics, Inc. | MNMD – Mind Medicine (MindMed) Inc. |
| MRNA – Moderna, Inc. | MRVI – Maravai LifeSciences Holdings, Inc. |
| MTEX – Mannatech, Incorporated |
Financial data and stock pages provided by
Fintel.io